Telomir Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership: Alan Weichselbaum, Chief Financial Officer
Reuters
10 Jun
<a href="https://laohu8.com/S/TELO">Telomir Pharmaceuticals</a> Inc. Files Initial Statement of Beneficial Ownership: Alan Weichselbaum, Chief Financial Officer
Telomir Pharmaceuticals Inc. has filed an initial statement of beneficial ownership. The document lists Alan Weichselbaum as the beneficial owner, serving as the Chief Financial Officer of the company. The full filing can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-014434), on June 10, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.